Castleark Management LLC Raises Holdings in Option Care Health, Inc. $OPCH

Castleark Management LLC increased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 146.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 147,760 shares of the company’s stock after acquiring an additional 87,840 shares during the period. Castleark Management LLC owned approximately 0.09% of Option Care Health worth $4,799,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in the stock. USA Financial Formulas purchased a new position in shares of Option Care Health in the 2nd quarter valued at about $26,000. Northwestern Mutual Wealth Management Co. grew its position in Option Care Health by 1,492.9% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock worth $31,000 after buying an additional 836 shares during the period. McIlrath & Eck LLC acquired a new stake in shares of Option Care Health during the 2nd quarter valued at approximately $37,000. Elevation Point Wealth Partners LLC purchased a new stake in shares of Option Care Health during the 2nd quarter worth approximately $40,000. Finally, Brooklyn Investment Group boosted its stake in shares of Option Care Health by 186.6% during the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company’s stock worth $42,000 after acquiring an additional 780 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Price Performance

NASDAQ:OPCH opened at $33.24 on Monday. The firm has a market cap of $5.28 billion, a price-to-earnings ratio of 26.38, a price-to-earnings-growth ratio of 2.24 and a beta of 0.79. The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85. The company’s 50-day moving average is $28.74 and its two-hundred day moving average is $29.32. Option Care Health, Inc. has a 12-month low of $22.29 and a 12-month high of $35.53.

Insider Activity at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 38,000 shares of the stock in a transaction dated Monday, November 3rd. The stock was acquired at an average price of $25.98 per share, with a total value of $987,240.00. Following the completion of the transaction, the director directly owned 413,390 shares in the company, valued at approximately $10,739,872.20. This trade represents a 10.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. 0.64% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft raised their price objective on Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, December 9th. Cowen assumed coverage on Option Care Health in a research report on Thursday, October 2nd. They issued a “hold” rating for the company. Wall Street Zen lowered shares of Option Care Health from a “buy” rating to a “hold” rating in a research report on Sunday. Citizens Jmp dropped their target price on shares of Option Care Health from $38.00 to $36.00 and set a “market outperform” rating for the company in a report on Friday, October 31st. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Option Care Health in a report on Monday, December 8th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $36.27.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.